CO48 A Non-Interventional Chart Review Study of Infliximab Precision-Guided Dosing Tool's Clinical Experience Program: Interim Analysis of Real-World Health Outcomes and Extrapolated Cost Savings
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.137
https://www.valueinhealthjournal.com/article/S1098-3015(24)00252-3/fulltext
Title :
CO48 A Non-Interventional Chart Review Study of Infliximab Precision-Guided Dosing Tool's Clinical Experience Program: Interim Analysis of Real-World Health Outcomes and Extrapolated Cost Savings
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00252-3&doi=10.1016/j.jval.2024.03.137
First page :
Section Title :
Open access? :
No
Section Order :
10768